CLCA2, a target of the p53 family, negatively regulates cancer cell migration and invasion

Cancer Biology and Therapy

Volumn 13, Issue 14, 2012, Pages 1512-1521

  Sasaki, Yasushi ^a   Koyama, Ryota ^a   Maruyama, Reo ^a   Hirano, Takehiro ^a   Tamura, Miyuki ^a   Sugisaka, Jun ^a   Suzuki, Hiromu ^a   Idogawa, Masashi ^a   Shinomura, Yasuhisa ^a   Tokino, Takashi ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell invasion; Cell migration; CLCA2; FAK; p53 family

Indexed keywords

CHLORIDE CHANNEL ACCESSORY 2; FOCAL ADHESION KINASE; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DNA DAMAGE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PROTEIN BINDING; SIGNAL TRANSDUCTION;

APOPTOSIS; BREAST NEOPLASMS; CELL MOVEMENT; CHLORIDE CHANNELS; DNA DAMAGE; DNA-BINDING PROTEINS; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84870677704     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.22280     Document Type: Article

References (37)

1. el-Deiry WS. Regulation of p53 downstream genes. Semin Cancer Biol 1998; 8:345-57; PMID:10101800; http://dx.doi.org/10.1006/scbi.1998.0097.
2. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10; PMID:11099028; http://dx.doi.org/10.1038/35042675.
3. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90:809-19; PMID:9288759; http://dx.doi.org/10.1016/S0092-8674(00)80540-1.
4. Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, et al. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 1998; 4:839-43; PMID:9662378; http://dx.doi.org/10.1038/nm0798-839.
5. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2:305-16; PMID:9774969; http://dx.doi.org/10.1016/S1097-2765(00)80275-0.
6. Dötsch V, Bernassola F, Coutandin D, Candi E, Melino G. p63 and p73, the ancestors of p53. Cold Spring Harb Perspect Biol 2010; 2:a004887; PMID:20484388; http://dx.doi.org/10.1101/cshperspect.a004887.
7. Barbieri CE, Pietenpol JA. p53 family members: similar biochemistry, different biology. Cancer Biol Ther 2005; 4:419-20; PMID:15908776; http://dx.doi.org/10.4161/cbt.4.4.1760.
8. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011; 333:1157-60; PMID:21798893; http://dx.doi.org/10.1126/science.1208130.
9. Zhang J, Chen X. The p53 family: prospect for cancer gene therapy. Cancer Biol Ther 2007; 6:116-8; PMID:17612008; http://dx.doi.org/10.4161/cbt.6.1.3790.
10. Chen F, Wang W, El-Deiry WS. Current strategies to target p53 in cancer. Biochem Pharmacol 2010; 80:724-30; PMID:20450892; http://dx.doi.org/10.1016/j. bcp.2010.04.031.
11. Leslie M. Brothers in arms against cancer. Science 2011; 331:1551-2; PMID:21436441; http://dx.doi.org/10.1126/science.331.6024.1551.
12. Lu C, Wang W, El-Deiry WS. Non-genotoxic antineoplastic effects of ellipticine derivative NSC176327 in p53-deficient human colon carcinoma cells involve stimulation of p73. Cancer Biol Ther 2008; 7:2039-46; PMID:19106635; http://dx.doi.org/10.4161/cbt.7.12.7461.
13. Sasaki Y, Negishi H, Koyama R, Anbo N, Ohori K, Idogawa M, et al. p53 family members regulate the expression of the apolipoprotein D gene. J Biol Chem 2009; 284:872-83; PMID:19001418; http://dx.doi.org/10.1074/jbc.M807185200.
14. Walia V, Ding M, Kumar S, Nie D, Premkumar LS, Elble RC. hCLCA2 Is a p53-Inducible Inhibitor of Breast Cancer Cell Proliferation. Cancer Res 2009; 69:6624-32; PMID:19654313; http://dx.doi.org/10.1158/0008-5472.CAN-08-4101.
15. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1992; 1:45-9; PMID:1301998; http://dx.doi.org/10.1038/ng0492-45.
16. Sasaki Y, Ishida S, Morimoto I, Yamashita T, Kojima T, Kihara C, et al. The p53 family member genes are involved in the Notch signal pathway. J Biol Chem 2002; 277:719-24; PMID:11641404; http://dx.doi.org/10.1074/jbc.M108080200.
17. Bustin SA, Li SR, Dorudi S. Expression of the Ca2+-activated chloride channel genes CLCA1 and CLCA2 is downregulated in human colorectal cancer. DNA Cell Biol 2001; 20:331-8; PMID:11445004; http://dx.doi.org/10.1089/ 10445490152122442.
18. Li X, Cowell JK, Sossey-Alaoui K. CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer. Oncogene 2004; 23:1474-80; PMID:14973555; http://dx.doi.org/10.1038/sj.onc.1207249.
19. Hoffmann EK. Ion channels involved in cell volume regulation: effects on migration, proliferation, and programmed cell death in non adherent EAT cells and adherent ELA cells. Cell Physiol Biochem 2011; 28:1061-78; PMID:22178996; http://dx.doi.org/10.1159/000335843.
20. Lang F, Föller M, Lang K, Lang P, Ritter M, Vereninov A, et al. Cell volume regulatory ion channels in cell proliferation and cell death. Methods Enzymol 2007; 428:209-25; PMID:17875419; http://dx.doi.org/10.1016/S0076- 6879(07)28011-5.
21. Ransom CB, O'Neal JT, Sontheimer H. Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J Neurosci 2001; 21:7674-83; PMID:11567057.
22. Abdel-Ghany M, Cheng HC, Elble RC, Pauli BU. Focal adhesion kinase activated by beta(4) integrin ligation to mCLCA1 mediates early metastatic growth. J Biol Chem 2002; 277:34391-400; PMID:12110680; http://dx.doi.org/10. 1074/jbc.M205307200.
23. Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci 2003; 116:1409-16; PMID:12640026; http://dx.doi.org/10.1242/jcs.00373.
24. Hamadi A, Bouali M, Dontenwill M, Stoeckel H, Takeda K, Rondé P. Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397. J Cell Sci 2005; 118:4415-25; PMID:16159962; http://dx.doi.org/10.1242/jcs.02565.
25. Sieg DJ, Hauck CR, Schlaepfer DD. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 1999; 112:2677-91; PMID:10413676.
26. Slack-Davis JK, Martin KH, Tilghman RW, Iwanicki M, Ung EJ, Autry C, et al. Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 2007; 282:14845-52; PMID:17395594; http://dx.doi.org/10.1074/jbc. M606695200.
27. Golubovskaya VM, Finch R, Kweh F, Massoll NA, Campbell-Thompson M, Wallace MR, et al. p53 regulates FAK expression in human tumor cells. Mol Carcinog 2008; 47:373-82; PMID:17999388; http://dx.doi.org/10.1002/mc.20395.
28. Schlaepfer DD, Mitra SK. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 2004; 14:92-101; PMID:15108811; http://dx.doi.org/10.1016/j.gde.2003.12.002.
29. Siesser PM, Hanks SK. The signaling and biological implications of FAK overexpression in cancer. Clin Cancer Res 2006; 12:3233-7; PMID:16740741; http://dx.doi.org/10.1158/1078-0432.CCR-06-0456.
30. Golubovskaya VM, Kweh FA, Cance WG. Focal adhesion kinase and cancer. Histol Histopathol 2009; 24:503-10; PMID:19224453.
31. Tanikawa C, Nakagawa H, Furukawa Y, Nakamura Y, Matsuda K. CLCA2 as a p53-inducible senescence mediator. Neoplasia 2012; 14:141-9; PMID:22431922.
32. Golubovskaya VM, Conway-Dorsey K, Edmiston SN, Tse CK, Lark AA, Livasy CA, et al. FAK overexpression and p53 mutations are highly correlated in human breast cancer. Int J Cancer 2009; 125:1735-8; PMID:19521985; http://dx.doi.org/10.1002/ijc.24486.
33. Lim ST, Chen XL, Lim Y, Hanson DA, Vo TT, Howerton K, et al. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell 2008; 29:9-22; PMID:18206965; http://dx.doi.org/10.1016/j.molcel.2007. 11.031.
34. Elble RC, Pauli BU. Tumor suppression by a proapoptotic calcium-activated chloride channel in mammary epithelium. J Biol Chem 2001; 276:40510-7; PMID:11483609; http://dx.doi.org/10.1074/jbc.M104821200.
35. Oshima Y, Sasaki Y, Negishi H, Idogawa M, Toyota M, Yamashita T, et al. Antitumor effect of adenovirus-mediated p53 family gene transfer on osteosarcoma cell lines. Cancer Biol Ther 2007; 6:1058-66; PMID:17568187; http://dx.doi.org/10.4161/cbt.6.7.4320.
36. Sasaki Y, Negishi H, Idogawa M, Yokota I, Koyama R, Kusano M, et al. p53 negatively regulates the hepatoma growth factor HDGF. Cancer Res 2011; 71:7038-47; PMID:22006999; http://dx.doi.org/10.1158/0008-5472.CAN-11-1053.
37. Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 2005; 102:13550-5; PMID:16141321; http://dx.doi.org/10.1073/pnas.0506230102.